No definition available.
Other congenital malformations, not elsewhere classified
Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
304 |
4. Check minimum number of eventsNone |
304 |
5. Include endpointsNone |
304 |
6. Filter based on genotype QC (FinnGen only) |
304 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q8
- Name in latin
- Aliae malformationes congenitae non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Other congenital malformations, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3086 | 1558 | 1514 |
| Only index persons | 2386 | 1228 | 1158 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 10.81 | 12.42 | 8.94 |
| Only index persons | 16.53 | 18.98 | 13.93 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 304 | 188 | 116 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | 32.31 | 33.26 | 30.77 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 277
- Matched controls
- 2770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q89.23
ICD-10 Finland
Cyst of the ductus thyreoglossus
+∞
93.1
84
*
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
+∞
69.8
64
*
ENB50
NOMESCO Finland
Excision of cyst or fistula of thyroglossic duct
633.1
54.5
52
*
Q89.9
ICD-10 Finland
Congenital malformation, unspecified
+∞
31.9
30
*
Q89.34
ICD-10 Finland
Cartagena syndrome (immotile cilia)
+∞
24.3
23
*
ZXD10
NOMESCO Finland
Scheduled procedure
3.7
23.2
150
671
Q89.30
ICD-10 Finland
Situs inversus with dextrocardia
+∞
22.2
21
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.6
21.7
139
604
Q89.88
ICD-10 Finland
Other specified congenital malformations
+∞
21.1
20
*
Z31.5
ICD-10 Finland
Genetic counselling
6.6
18.3
49
87
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
17.6
119
517
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
16.8
16
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.6
15.6
58
151
Q89.22
ICD-10 Finland
Permanent ductus thyreoglossus
+∞
14.7
14
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.6
14.7
44
90
ZXE00
NOMESCO Finland
One hour or less
2.7
14.3
143
776
Z2446
NOMESCO Finland
Social worker
4.0
13.7
59
176
Q18.8
ICD-10 Finland
Other specified congenital malformations of face and neck
42.3
13.3
16
*
J47
ICD-10 Finland
Bronchiectasis
19.1
12.2
18
10
R4110
NOMESCO Finland
Physiotherapy
2.8
11.8
94
434
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
31.6
11.8
15
5
Z2445
NOMESCO Finland
Psychologist
4.0
11.5
47
133
Z3226
NOMESCO Finland
Physiotherapist
2.9
11.4
82
353
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
7.6
11.3
26
37
XA800
NOMESCO Finland
Neuropsychological investigation
4.7
10.8
37
88
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
10.8
88
408
R62.0
ICD-10 Finland
Delayed milestone
6.5
10.6
27
45
Z3229
NOMESCO Finland
Other healthcare associate professional
3.8
9.9
43
128
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.9
9.6
31
69
WX402
NOMESCO Finland
General anaesthesia
2.7
9.6
72
315
Q24.0
ICD-10 Finland
Dextrocardia
103.4
9.5
10
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
9.3
62
252
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
9.1
41
126
Z2221
NOMESCO Finland
Medical doctor
2.4
9.1
98
519
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
13.1
9.0
15
12
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
8.7
62
261
UDC00
NOMESCO Finland
Ear microscopy
3.8
8.6
37
109
F82
ICD-10 Finland
Specific developmental disorder of motor function
8.3
8.5
18
23
J45.9
ICD-10 Finland
Asthma, unspecified
2.7
8.4
61
260
Q89.00
ICD-10 Finland
Asplenia (congenital)
+∞
8.4
8
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.3
8.1
42
144
Z3231
NOMESCO Finland
Registered nurse
2.2
8.0
99
555
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
3.5
7.9
36
112
RS220
NOMESCO Finland
NA
9.8
7.9
15
16
Q21.10
ICD-10 Finland
Persistent ostium secundum
9.8
7.9
15
16
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.7
7.9
26
60
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.0
7.9
31
85
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.3
7.8
20
34
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.6
7.8
35
107
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.8
7.8
25
56
ZXA00
NOMESCO Finland
Right side
2.5
7.8
67
314
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
6.1
7.7
20
35
ZXD20
NOMESCO Finland
Day surgery
2.9
7.7
47
180
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
9.3
7.6
15
17
H65.3
ICD-10 Finland
Chronic mucoid otitis media
3.8
7.6
32
93
RL140
NOMESCO Finland
NA
10.5
7.6
14
14
F83
ICD-10 Finland
Mixed specific developmental disorders
5.9
7.5
20
36
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
7.5
58
255
7593A
ICD-9 Finland
Other and unspecified congenital anomalies, Situs inversus
+∞
7.3
7
*
Q89.20
ICD-10 Finland
Congenital malformation of pituitary gland
+∞
7.3
7
*
ZXA05
NOMESCO Finland
Left side
2.4
7.3
67
325
R1260
NOMESCO Finland
Evaluation of communicative skills
16.3
7.3
11
7
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
7.3
62
288
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.0
7.2
41
150
UGC02
NOMESCO Finland
Rigid bronchoscopy
20.7
7.2
10
5
J01MA14
ATC
moxifloxacin; systemic
4.0
7.1
27
72
H52.2
ICD-10 Finland
Astigmatism
7.3
7.1
16
23
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
7.0
105
632
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
7.0
58
265
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.5
6.9
31
96
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.4
6.8
64
313
R03BB04
ATC
tiotropium bromide; inhalant
4.3
6.8
24
60
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
6.8
46
188
J45.1
ICD-10 Finland
Nonallergic asthma
3.2
6.7
35
121
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
12.7
6.6
11
9
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.6
6.5
21
48
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
5.8
6.4
17
31
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
6.4
52
235
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
9.6
6.3
12
13
XF404
NOMESCO Finland
Ambulatory ECG
3.3
6.3
30
97
ZXA10
NOMESCO Finland
Bilateral
2.4
6.3
58
278
Q89.21
ICD-10 Finland
Congenital malformation of the thyroid gland
+∞
6.3
6
*
Q89.38
ICD-10 Finland
Another site inversus
+∞
6.3
6
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
27.4
6.3
8
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
6.0
6.2
16
28
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.6
6.2
20
46
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
12.9
6.1
10
8
N30.9
ICD-10 Finland
Cystitis, unspecified
4.5
6.1
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023419) Bacteria identified in Sputum by Culture
21
17
13.20
21.41
9.0
2.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
75
342
2.58
10.57
3.4
3.3
ng/l
620.6
393.8
0.32
41
218
(3042936) Bacteria identified in Isolate by Culture
62
271
2.62
9.45
2.4
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
65
292
2.56
9.37
13.3
10.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
90
473
2.28
9.14
5.3
4.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
51
210
2.72
8.71
2.3
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
64
297
2.46
8.56
2.2
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
62
285
2.48
8.46
2.7
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
35
5.09
7.98
2.5
5.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
49
207
2.63
7.94
2.3
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
92
517
2.12
7.75
2.8
2.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
181
1300
1.97
7.55
7.9
7.1
e9/l
0.6
0.5
2.31
164
1121
(3006315) Basophils [#/volume] in Blood
181
1305
1.96
7.41
7.9
7.1
e9/l
0.0
0.0
0.78
164
1124
(3003396) Base excess in Arterial blood by calculation
44
183
2.64
7.34
8.4
12.3
mmol/l
0.8
0.7
0.03
34
148
(3002032) Base excess in Venous blood by calculation
64
317
2.29
7.33
9.3
8.2
mmol/l
1.9
1.6
0.37
56
245
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
38
4.68
7.27
4.4
2.0
—
—
—
0
0
(4062490)
15
30
5.21
7.26
1.6
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
184
1348
1.92
7.03
8.6
7.7
e9/l
0.2
0.2
0.11
166
1186
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
73
389
2.15
6.98
4.5
3.1
e6/l
0.7
0.7
0.07
42
213
(3022096) Basophils/100 leukocytes in Blood
168
1199
1.90
6.91
8.0
7.4
%
0.7
0.7
0.23
160
1140
(3006504) Eosinophils/100 leukocytes in Blood
172
1243
1.88
6.74
7.9
7.2
%
2.9
3.0
0.09
166
1181
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
45
4.19
6.72
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
59
3.75
6.72
2.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
59
3.75
6.72
2.1
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
109
681
1.94
6.69
3.0
2.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
172
1250
1.87
6.56
7.9
7.4
%
8.6
8.2
0.89
166
1199
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
71
383
2.11
6.54
5.0
3.8
ng/l
848.1
773.2
0.15
62
304
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
146
1010
1.86
6.49
15.9
8.8
mmol/l
1.2
1.2
1.14
139
937
(3030467) Casts [#/volume] in Urine by Automated count
104
647
1.92
6.42
5.6
3.4
e6/l
0.2
0.3
0.54
78
480
(3024561) Albumin [Mass/volume] in Serum or Plasma
122
803
1.87
6.31
6.8
5.8
g/l
36.8
37.0
0.13
116
767
(40758558) Short blood count panel - Blood
110
701
1.89
6.29
8.9
7.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
120
787
1.87
6.27
5.5
3.5
—
—
—
0
0
(3002256) Pathology report gross observation
51
245
2.30
6.23
1.3
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
182
1362
1.84
6.16
8.0
7.0
e9/l
2.1
2.2
0.20
166
1206
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
70
386
2.06
6.05
4.9
3.2
e6/l
3.1
2.7
0.09
38
213
(3018095) Leukocytes [#/volume] in Urine
128
865
1.83
6.02
6.8
4.1
e6/l
30.1
46.9
0.41
89
574
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
53
263
2.23
5.99
3.8
2.9
%
18.9
23.2
1.93
47
236
(36304419) Bacteria [Presence] in Urine
104
662
1.87
5.90
5.4
3.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
175
1306
1.80
5.86
7.9
7.2
%
31.7
32.0
0.15
167
1252
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
9
11.44
5.83
10.6
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
110
715
1.84
5.83
5.5
3.5
e6/l
16.9
132.9
0.68
83
538
(3000850) Epithelial cells [#/volume] in Urine
81
477
1.95
5.81
3.8
2.8
e6/l
4.9
8.3
1.05
75
415
(3018418) pH of Serum or Plasma
93
583
1.86
5.48
5.3
3.7
ph
7.4
7.4
—
9
96
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
96
2.87
5.42
11.4
16.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
150
1089
1.75
5.36
16.2
8.9
mmol/l
1.2
1.2
1.20
139
952
(42870588) Differential panel, method unspecified - Blood
130
908
1.75
5.31
8.3
7.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
122
837
1.76
5.30
2.0
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
94
2.81
5.05
1.7
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
43
211
2.21
4.98
3.7
3.8
g/l
0.2
0.2
0.35
43
204
(3026782) Osmolality of Urine
76
460
1.87
4.95
4.2
2.8
mosm/kgh2o
582.8
570.9
0.14
67
392
(3000494) Fungus identified in Specimen by Culture
48
247
2.12
4.94
2.7
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
189
1484
1.72
4.93
10.4
9.9
e9/l
4.1
3.8
0.80
172
1279
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
140
1015
1.70
4.89
4.4
4.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
35
159
2.36
4.84
24.8
17.9
inr
1.3
1.4
—
6
26
(3026008) Bacteria identified in Urine by Culture
92
598
1.77
4.72
3.1
2.5
—
—
—
0
0
(44790049)
12
29
4.27
4.67
2.0
2.0
—
—
—
0
0
(44806118)
12
29
4.27
4.67
2.0
2.0
—
—
—
0
0
(44790048)
12
29
4.27
4.67
2.0
2.0
—
—
—
0
0
(44790047)
12
29
4.27
4.67
2.0
2.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
27
111
2.57
4.61
12.0
12.3
%
0.6
0.7
0.48
27
111
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
84
539
1.77
4.48
2.7
2.5
mg/l
2.9
2.9
0.01
79
460
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
12
30
4.12
4.48
4.0
4.4
%
86.0
98.4
1.06
12
30
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
132
962
1.66
4.40
3.5
2.7
nmol/l
70.5
73.2
0.56
127
881
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
227
1906
1.75
4.34
4.8
3.8
pmol/l
14.4
14.5
0.21
220
1745
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
56
3.16
4.31
1.8
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
202
1646
1.68
4.30
8.5
6.6
u/l
96.5
90.2
0.70
195
1543
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
6
11.90
4.29
2.3
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
86
563
1.74
4.25
4.3
3.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
77
491
1.76
4.17
2.9
2.6
mg/l
1.8
1.1
0.45
63
357
(3019550) Sodium [Moles/volume] in Serum or Plasma
266
2355
2.04
4.16
22.5
12.6
mmol/l
139.4
139.6
0.77
261
2289
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
32
3.86
4.12
2.3
3.9
—
620.1
—
0
7
(3032080) INR in Blood by Coagulation assay
99
680
1.68
4.09
9.5
5.9
inr
1.3
1.1
0.62
21
210
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
108
759
1.66
4.08
5.3
3.5
u/l
28.7
29.9
0.28
103
724
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
54
312
1.89
4.01
21.0
10.8
mmol/l
24.8
24.9
0.08
54
312
(3027945) Reticulocytes/100 erythrocytes in Blood
46
252
1.97
3.99
5.1
4.4
%
1.6
1.6
0.03
46
239
(3023103) Potassium [Moles/volume] in Serum or Plasma
266
2364
2.00
3.98
22.6
12.6
mmol/l
3.9
3.9
0.14
259
2286
(3037121) Protein [Mass/volume] in Urine
23
96
2.51
3.83
4.2
5.9
g/l
0.2
0.4
0.74
18
58
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
137
2.23
3.69
2.8
2.2
ml/min/173m2
80.8
78.1
0.13
13
58
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
274
2481
2.06
3.56
19.5
11.4
mg/l
19.6
21.3
0.58
228
1828
(3019060) Gas panel - Arterial blood
21
87
2.52
3.56
2.7
9.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
17
5.42
3.53
1.8
3.0
ug/l
150.4
165.1
—
9
17
(3052851) Hemolysis interference index of Serum or Plasma
18
70
2.67
3.45
4.1
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
193
1600
1.56
3.43
5.7
4.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
135
2.18
3.40
2.2
2.1
u/l
11.6
6.0
0.74
16
100
(3014111) Lactate [Moles/volume] in Serum or Plasma
37
199
1.98
3.39
10.8
10.8
mmol/l
1.1
1.2
0.48
37
186
(40761511) CBC panel - Blood by Automated count
281
2577
2.20
3.38
15.4
9.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
10
7.13
3.38
5.4
2.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
48
3.01
3.34
6.1
8.9
u/ml
0.4
0.3
—
9
28
(3022313) Gas panel - Capillary blood
42
238
1.89
3.31
19.2
7.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
93
661
1.59
3.25
2.0
1.7
pmol/l
102.2
96.6
0.50
56
338
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
111
2.26
3.22
1.8
1.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
24
112
2.24
3.16
12.5
12.0
%
1.5
1.3
0.43
24
112
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
50
2.89
3.13
1.9
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
248
2203
1.68
3.10
5.3
4.3
mu/l
1.8
1.8
0.04
243
2046
(3023323) Follitropin [Units/volume] in Serum or Plasma
34
187
1.92
2.93
1.9
1.9
iu/l
16.4
18.7
0.13
21
149
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
6
9
6.77
2.88
1.8
2.6
ug/g
140.5
151.4
—
6
9
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
59
2.62
2.83
2.3
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
31
3.30
2.80
2.0
2.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
31
168
1.94
2.79
3.3
2.0
nmol/l
11.3
13.3
0.69
24
155
(3013826) Glucose [Moles/volume] in Serum or Plasma
160
1313
1.46
2.71
8.9
5.8
mmol/l
6.2
6.3
0.22
152
1205
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
10
6.09
2.71
5.5
7.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
134
2.03
2.69
2.7
1.7
—
—
—
0
0
(4010399)
26
134
2.03
2.69
2.0
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
32
179
1.88
2.64
3.2
3.5
e9/l
68.9
67.4
0.10
19
124
(3009261) Glucose [Presence] in Urine by Test strip
144
1163
1.45
2.63
4.4
3.3
estimate
0.0
0.0
0.00
15
212
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
25
3.68
2.59
2.0
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
295
2819
2.57
2.55
26.1
16.8
e12/l
4.5
4.6
1.16
289
2732
(3021601) Nitrite [Presence] in Urine by Test strip
142
1149
1.44
2.54
6.8
4.6
estimate
0.0
0.0
0.00
15
221
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
44
275
1.70
2.52
19.6
7.0
mmol/l
1.5
1.2
0.48
30
197
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
57
2.53
2.48
1.4
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
139
1.95
2.45
2.0
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
104
2.09
2.42
2.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
295
2821
2.54
2.42
26.2
16.8
e9/l
7.0
6.7
1.83
290
2734
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
51
339
1.61
2.32
1.9
1.7
%
1.3
1.4
0.21
46
306
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
6
13
4.68
2.28
1.5
2.3
%
89.3
133.2
—
6
13
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
18
3.95
2.26
1.4
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
18
3.95
2.26
1.4
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
18
3.95
2.26
1.4
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
14
60
2.40
2.25
1.9
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
98
754
1.44
2.25
1.6
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
13
54
2.47
2.23
4.8
4.2
umol/l
35.8
35.0
0.05
13
49
(3009466) Valproate [Moles/volume] in Serum or Plasma
11
42
2.68
2.21
5.3
4.6
umol/l
412.8
354.6
0.75
11
37
(3035350) Ketones [Presence] in Urine by Test strip
139
1142
1.40
2.20
4.2
3.2
estimate
0.0
0.0
0.00
14
211
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
61
2.36
2.18
2.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
30
3.06
2.16
1.2
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
83
623
1.46
2.16
3.4
3.5
mmol/l
8.3
8.2
0.09
75
548
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
43
279
1.63
2.16
8.1
4.2
umol/l
11.8
8.3
0.31
38
237
(3026493) Urate [Moles/volume] in Serum or Plasma
64
456
1.51
2.15
3.6
3.4
umol/l
343.2
5958.4
1.90
57
407
(3021960) Folate [Moles/volume] in Serum or Plasma
56
391
1.53
2.07
1.6
1.4
nmol/l
21.0
20.9
0.02
51
335
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
20
3.56
2.06
1.6
2.0
%
92.0
122.9
—
7
20
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
20
3.56
2.06
5.0
3.0
umol/l
25.9
29.3
—
7
20
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
16
76
2.17
2.06
6.1
4.5
%
57.2
52.3
0.35
16
76
(3000492) Spirometry study
35
218
1.68
2.05
2.3
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
195
1710
1.39
2.02
4.9
3.9
mm/h
10.4
8.9
0.90
185
1588
(3007461) Platelets [#/volume] in Blood
294
2816
2.34
1.96
26.2
16.8
e9/l
266.6
260.7
0.75
287
2737
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
46
2.44
1.87
2.1
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
33
208
1.66
1.86
1.4
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
17
3.58
1.84
2.2
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
60
2.22
1.80
1.1
4.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
29
2.80
1.80
2.4
3.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
29
2.80
1.80
1.1
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
29
2.80
1.80
1.9
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
33
210
1.64
1.80
1.3
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
33
211
1.63
1.77
1.3
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
133
1.79
1.75
3.5
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
33
212
1.62
1.74
1.3
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
13
3.89
1.72
2.0
2.7
u/ml
1002.2
650.9
—
5
13
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
19
3.20
1.67
1.5
1.4
umol/l
13.7
19.3
—
6
19
(4198724)
7
25
2.84
1.66
1.7
2.1
—
—
—
0
0
(3020891) Body temperature
13
63
2.11
1.62
5.7
5.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
14
3.61
1.62
8.4
5.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
14
3.61
1.62
1.8
1.0
%
78.2
149.8
—
5
14
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
14
3.61
1.62
4.4
3.4
umol/l
66.4
60.2
—
5
14
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
32
2.54
1.61
2.3
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
26
2.73
1.59
1.1
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
20
3.04
1.59
1.2
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
50
2.25
1.59
3.1
11.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
100
1.85
1.56
1.3
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
2.4
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
15
3.37
1.53
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
27
2.63
1.52
5.0
2.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
37
2.48
1.49
2.0
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
45
2.26
1.48
2.8
12.0
%
77.0
69.5
—
10
45
(3020393) Adenovirus Ag [Presence] in Stool
6
22
2.76
1.44
4.0
2.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
40
2.29
1.41
1.1
5.4
—
—
—
0
0
(44813793)
6
23
2.64
1.37
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
17
2.97
1.36
1.4
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
260
2450
1.42
1.36
22.2
13.2
%
39.8
40.2
0.61
221
2041
(3035933) Granulocytes/100 leukocytes in Blood
0
37
0.00
1.35
0.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
91
1.80
1.31
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
26
170
1.58
1.31
1.4
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
204
1860
1.29
1.30
5.2
4.5
mmol/mol
37.4
38.2
0.71
199
1746
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
18
2.81
1.29
1.0
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
107
1.73
1.29
1.2
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
29
196
1.53
1.27
1.4
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
25
2.43
1.25
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
78
1.83
1.23
1.4
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
296
0.62
1.22
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
37
2.19
1.22
1.4
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
37
2.19
1.22
1.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
19
2.66
1.22
1.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
19
2.66
1.22
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
79
1.81
1.19
1.4
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
57
1.96
1.18
13.8
8.1
—
520.3
—
0
11
(3015377) Calcium [Moles/volume] in Serum or Plasma
82
674
1.30
1.18
3.2
3.0
mmol/l
2.4
2.4
1.38
77
601
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
33
0.00
1.17
0.0
2.7
—
39.0
—
0
33
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
20
2.52
1.15
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
138
1213
1.25
1.14
12.8
9.5
e9/l
0.0
0.0
0.75
110
964
(40761535) Cells panel - Urine sediment
21
136
1.58
1.12
4.0
3.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
84
698
1.28
1.11
2.1
2.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
31
2.29
1.11
1.1
4.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
81
1.76
1.11
1.4
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
12
66
1.85
1.10
1.1
1.2
—
—
—
0
0
(3013512) EKG study
58
459
1.33
1.09
3.1
3.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
21
2.40
1.09
1.2
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
153
1367
1.24
1.08
3.8
2.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
230
2152
1.28
1.07
3.7
3.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
75
1.77
1.04
2.0
2.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
47
1.94
1.03
4.6
3.1
u/ml
12.7
3.6
—
9
42
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
26
181
1.48
1.02
3.0
2.6
u/l
134.8
2007.4
0.79
13
68
(3039162) Centromere protein B Ab [Units/volume] in Serum
7
35
2.02
1.00
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
56
448
1.31
0.98
3.5
4.1
mg/mmol
5.5
11.6
1.03
36
292
(3051651) Icteric interference index of Serum or Plasma
5
23
2.19
0.98
5.8
2.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
23
2.19
0.98
1.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
23
2.19
0.98
4.8
3.9
nmol/l
1.7
3.5
—
5
23
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
217
1.42
0.98
1.8
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
31
0.00
0.97
0.0
14.0
—
6.0
—
0
24
(40768443) Skin Pathology biopsy report
13
77
1.72
0.96
1.4
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
69
825
0.79
0.96
2.4
2.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
28
2.17
0.92
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
28
2.17
0.92
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
119
1.54
0.90
1.1
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
34
256
1.37
0.90
1.9
1.6
nmol/l
938.4
1203.8
1.26
29
194
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
29
2.09
0.90
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
29
2.09
0.90
3.2
17.5
%
12.0
12.8
—
6
29
(4035726)
23
161
1.46
0.89
1.9
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
42
1.93
0.89
2.0
2.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
87
1.64
0.89
1.1
1.0
u/ml
5.7
6.0
—
8
45
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
209
1952
1.23
0.89
14.7
9.5
ml/min/173m2
93.2
93.0
0.04
167
1514
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
38
292
1.34
0.88
2.4
2.4
mmol/l
2.5
2.4
0.76
32
260
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
72
1.69
0.86
1.8
2.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
46
1.76
0.83
1.9
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
147
1.46
0.82
1.3
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
199
0.64
0.81
5.1
3.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
(4034850)
10
59
1.72
0.76
6.6
8.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
24
2.10
0.75
1.0
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
252
0.70
0.74
1.4
1.6
—
—
—
0
0
(4306422)
7
38
1.86
0.74
1.3
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
262
2524
1.28
0.73
11.7
8.9
u/l
27.4
26.2
0.26
253
2438
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
85
1.55
0.70
2.1
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
33
260
1.30
0.67
3.7
4.3
%
21.0
22.4
0.25
13
114
(3014051) Protein [Presence] in Urine by Test strip
7
43
1.64
0.67
1.1
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
43
1.64
0.67
1.7
3.6
%
62.3
55.0
—
7
43
(3017143) Hepatitis C virus Ab [Presence] in Serum
46
379
1.25
0.67
2.1
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
389
1.25
0.66
1.2
1.2
iu/ml
35.1
33.4
0.05
14
110
(3003888) Timothy IgE Ab [Units/volume] in Serum
18
129
1.42
0.65
1.1
1.2
u/ml
5.3
5.4
—
10
98
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
96
1.48
0.62
2.0
2.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
30
1.68
0.61
5.0
5.8
ug/l
1.6
1.9
—
5
30
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
30
1.68
0.61
2.0
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
60
514
1.21
0.61
3.4
3.1
kg/l
1.0
1.0
0.32
12
86
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
62.8
—
0
7
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
51
431
1.22
0.60
3.5
3.4
mg/l
32.2
87.8
1.49
37
285
(40760892) CBC W Ordered Manual Differential panel - Blood
64
554
1.20
0.59
4.0
4.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
149
0.66
0.58
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
54
1.49
0.57
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
65
1.56
0.56
1.6
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.56
2.0
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
82
1.48
0.55
4.2
2.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
82
1.48
0.55
2.0
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
9
60
1.52
0.55
1.8
1.1
—
46.4
—
0
16
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
178
1.32
0.55
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
11
158
0.68
0.54
7.6
4.8
%
1.0
0.5
—
5
42
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
12
83
1.46
0.52
2.2
1.7
—
—
—
0
0
(4094501)
6
40
1.51
0.52
1.2
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
17
128
1.35
0.49
1.1
1.1
u/ml
1.4
2.3
—
6
40
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
46
1.53
0.48
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
23
183
1.28
0.46
2.1
2.2
—
20.5
—
0
10
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
49
1.44
0.46
1.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
37
435
0.83
0.46
1.9
2.6
ug/g
62.1
90.8
0.77
32
341
(40768797) Stomach Pathology biopsy report
31
257
1.23
0.45
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
121
1.34
0.45
1.4
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
10
69
1.46
0.45
1.9
1.7
iu/l
10.6
8.1
—
5
22
(3001019) Free T4 and TSH panel - Serum or Plasma
19
148
1.30
0.44
1.7
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
78
1.43
0.43
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
149
1.29
0.43
1.4
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
87
1.39
0.43
1.3
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
87
1.39
0.43
1.4
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
21
168
1.27
0.41
1.1
1.2
—
31.1
—
0
5
(4146454)
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
79
1.41
0.41
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
59
1.37
0.41
1.0
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
8.7
—
8.0
—
0
17
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
14
106
1.34
0.40
1.1
1.1
—
9.2
—
0
17
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
142
1.28
0.39
1.2
1.2
u/ml
1.0
3.2
1.06
12
87
(3045424) Erythrocytes [Presence] in Urine
5
35
1.44
0.39
1.8
1.5
—
—
—
0
0
(4268621)
5
35
1.44
0.39
2.2
2.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
35
1.44
0.39
1.0
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
134
1.28
0.37
1.6
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.37
1.6
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
135
0.73
0.37
9.8
3.6
mmol/l
1.2
1.2
—
10
113
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
70
1.29
0.37
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
41
1.47
0.36
1.0
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
126
1.28
0.36
1.1
1.2
u/ml
0.4
0.8
—
8
89
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
43
1.40
0.35
1.5
3.2
e9/l
5.6
4.3
—
6
43
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
177
0.78
0.34
1.3
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
45
1.34
0.34
1.2
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
10
132
0.75
0.33
2.8
2.3
u/ml
52.6
32.3
—
10
126
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
23
194
1.20
0.30
2.8
2.8
ug/l
0.7
0.8
0.29
15
113
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
57
1.23
0.29
1.0
1.2
—
15.7
—
0
6
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
57
1.23
0.29
1.3
1.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
10
76
1.33
0.28
1.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
128
0.77
0.27
2.5
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
88
825
1.09
0.26
2.1
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
209
2034
1.09
0.25
4.1
3.5
mmol/l
5.8
5.7
0.27
199
1873
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
75
1.21
0.25
1.8
2.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
78
831
0.92
0.24
1.3
1.6
u/ml
5.7
2.7
0.26
13
194
(1761482) Bacteria [#/volume] in Urine by Culture
5
39
1.29
0.23
7.0
3.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
94
0.74
0.22
2.1
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
172
1.17
0.22
1.8
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
40
1.25
0.22
5.8
3.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
38
344
1.12
0.22
1.2
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
10.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
11
0.00
0.21
0.0
5.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
24.5
—
0.5
—
0
11
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
198
0.85
0.21
7.1
6.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
1.0
—
0
7
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
2.3
—
0
7
(3016031) Almond IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
2.8
—
0
12
(3034426) Prothrombin time (PT)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
89
1.24
0.21
2.0
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
43
1.17
0.21
3.2
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.6
—
0
7
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
10.5
—
263.2
—
0
6
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
3.0
—
0
8
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
228
0.87
0.19
1.8
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
59
629
0.92
0.19
3.4
2.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
147
1.17
0.18
1.6
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
166
1.15
0.18
3.2
3.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
37
339
1.10
0.18
1.5
1.4
titre
413.3
362.6
—
6
62
(1002224) Polysomnography panel
10
121
0.82
0.18
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
60
1.17
0.18
1.1
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
80
762
1.07
0.17
1.8
1.6
g/l
2.0
2.0
0.02
48
424
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
34
312
1.10
0.16
1.7
1.6
pmol/l
547.2
24723695.6
0.50
28
271
(3017181) Myelocytes/100 leukocytes in Blood
15
172
0.87
0.16
6.9
5.0
%
1.2
0.7
—
6
58
(3029937) Albumin [Presence] in Urine by Test strip
55
583
0.93
0.15
4.2
3.4
estimate
0.0
0.0
0.50
14
217
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
58
548
1.07
0.15
2.2
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
60
568
1.07
0.15
2.2
2.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
30
275
1.10
0.15
2.4
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
93
1.19
0.14
1.5
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
10
85
1.18
0.12
2.3
1.8
u/ml
206.2
201.4
—
10
46
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
36
337
1.08
0.12
2.5
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
41
387
1.07
0.11
1.3
1.2
u/ml
12.7
7.3
0.21
15
153
(3019832) Treponema pallidum Ab [Presence] in Serum
41
433
0.94
0.11
2.0
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
125
0.88
0.10
2.3
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
45
1.11
0.10
2.0
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
197
1995
0.96
0.08
3.8
3.3
mmol/l
1.2
1.2
0.23
192
1856
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
64
0.78
0.08
1.4
1.2
pmol/l
59.6
64.0
—
5
59
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
206
2082
0.97
0.07
4.2
3.6
mmol/l
1.4
1.5
0.90
201
1942
(3004588) Protein electrophoresis panel - Serum or Plasma
8
77
1.04
0.07
1.9
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
23
216
1.07
0.07
1.2
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
90
0.89
0.07
1.4
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
110
1.09
0.05
1.1
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
66
645
1.03
0.05
3.8
2.9
ng/l
14.2
20.7
1.12
37
352
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
21
200
1.05
0.04
2.6
3.6
%
32.4
32.2
0.02
14
126
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
13
139
0.93
0.03
4.0
4.1
ug/l
3.2
11.2
—
6
107
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
84
853
0.98
0.03
4.1
3.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
43
441
0.97
0.03
1.6
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
241
1.04
0.03
2.2
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
51
500
1.02
0.02
1.6
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
106
0.94
0.01
1.7
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
114
1.05
0.01
2.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
114
1.05
0.01
2.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
114
1.05
0.01
2.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
114
1.05
0.01
2.0
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
16
161
0.99
0.00
6.5
5.2
%
0.2
0.2
—
6
53
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
221
1.00
0.00
1.1
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
16
155
1.03
0.00
6.5
5.2
%
0.0
0.2
—
6
49
(3019225) pH of Specimen
15
155
0.97
0.00
4.8
5.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
52
524
0.99
0.00
2.4
2.2
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
97
0.93
0.00
2.6
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
55
0.91
0.00
1.2
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.5
—
220.6
—
0
8
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
56
0.89
0.00
2.2
2.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
4.3
—
0
5
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
94
0.96
0.00
2.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
94
0.96
0.00
2.2
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
59
0.84
0.00
6.6
3.2
u/ml
20.0
2394.1
—
5
52
(3029396) Erythrocyte agglutination [Presence] in Blood
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
10.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
49
1.02
0.00
1.8
1.7
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
22.4
—
0
6
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED | 2.187 [1.37, 3.49] | 0.001 |
| Birth year | 1.0 [0.99, 1.01] | 0.963 |
During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 1318 females with Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED | 2.337 [1.7, 3.21] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.018 |
During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 1304 males with Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.212% | 0.481% |
| 5 | 1.422% | 2.848% |
| 10 | 3.576% | 6.989% |
| 15 | 6.823% | 13.087% |
| 20 | 12.109% | 21.146% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED – Other congenital malformations, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data